Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of the Delta Variant B.1.617.2 COVID-19
Shayan Shiehzadegan, Nazanin Alaghemand, Michael Fox, et al.
Clinics and Practice (2021) Vol. 11, Iss. 4, pp. 778-784
Open Access | Times Cited: 263

Showing 1-25 of 263 citing articles:

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Manish Dhawan, Abhilasha Sharma, Priyanka Choudhary, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 87
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 71
Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants
Michaela Krivosova, Juliana Hanusrichterová, Vincent Lučanský, et al.
Bratislavské lekárske listy/Bratislava medical journal (2025)
Open Access | Times Cited: 1
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
Haifa Khemiri, Kaouther Ayouni, Henda Triki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 63
CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
Lairun Jin, Zhuopei Li, Xiaoyin Zhang, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 55
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Lactoferrin for COVID-19 prevention, treatment, and recovery
Ecem Bolat, Furkan Eker, Merve Kaplan, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 39
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, et al.
Folia Microbiologica (2022) Vol. 68, Iss. 1, pp. 17-28
Open Access | Times Cited: 38
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
Tao Dong, Mingyang Wang, Junchong Liu, et al.
Chemical Science (2023) Vol. 14, Iss. 23, pp. 6149-6206
Open Access | Times Cited: 35
SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19
Ariana Arduini, Frederique Laprise, Chen Liang
Viruses (2023) Vol. 15, Iss. 4, pp. 871-871
Open Access | Times Cited: 22
Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
Md. Aminul Islam, Shatila Shahi, Abdullah Al Marzan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
CRISPR techniques and potential for the detection and discrimination of SARS-CoV-2 variants of concern
Huyan Xiao, Jianyu Hu, Camille Huang, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 161, pp. 117000-117000
Open Access | Times Cited: 21
Indiscriminate SARS-CoV-2 multivariant detection using magnetic nanoparticle-based electrochemical immunosensing
Ceren Durmus, Simge Balaban Hanoglu, Duygu Harmancı, et al.
Talanta (2022) Vol. 243, pp. 123356-123356
Open Access | Times Cited: 35
Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
Camino Trobajo‐Sanmartín, Iván Martínez‐Baz, Ana Miqueleiz, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 35
Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern
Robério Amorim de Almeida Pondé
Virology (2022) Vol. 572, pp. 44-54
Open Access | Times Cited: 35
Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants
Dídac Florensa, Jordi Nofre, Radu Spaimoc, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Structural modeling of Omicron spike protein and its complex with human ACE-2 receptor: Molecular basis for high transmissibility of the virus
Tirthankar Koley, Manoj Kumar, Arunima Goswami, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 592, pp. 51-53
Open Access | Times Cited: 29
The Deltacron conundrum: Its origin and potential health risks
Saria Farheen, Yusha Araf, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5096-5102
Closed Access | Times Cited: 29
Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies
Juan C. Almagro, Gabriela Mellado‐Sánchez, Martha Pedraza‐Escalona, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9763-9763
Open Access | Times Cited: 29
Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide Polysulfate
Fuming Zhang, Peng He, André L. Rodrigues, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 258-258
Open Access | Times Cited: 28
SARS-CoV-2 Delta and Omicron Variants Surge in Curitiba, Southern Brazil, and Its Impact on Overall COVID-19 Lethality
Douglas Adamóski, Valter A. Baura, Ana Carolina Rodrigues, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 809-809
Open Access | Times Cited: 28
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
Omid Gholizadeh, Saman Yasamineh, Parya Amini, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Universal access to comprehensive COVID-19 services for everyone in Thailand
Viroj Tangcharoensathien, Saranya Sachdev, Shaheda Viriyathorn, et al.
BMJ Global Health (2022) Vol. 7, Iss. 6, pp. e009281-e009281
Open Access | Times Cited: 27
Multi‐species outbreak of SARS‐CoV‐2 Delta variant in a zoological institution, with the detection in two new families of carnivores
Matthew C. Allender, Michael J. Adkesson, Jennifer N. Langan, et al.
Transboundary and Emerging Diseases (2022) Vol. 69, Iss. 5
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top